{"id":"W4394581977","doi":"10.1080/14728214.2024.2340723","title":"Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Dalhousie University","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Clinical trial; Intensive care medicine; Pulmonary fibrosis; Disease; Lung; Internal medicine; Fibrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002276108,0.0006273407,0.0017229,0.0007399529,0.0002350018,0.00005422396,0.0002454781,0.0003167347,0.0003891074],"category_scores_gemma":[0.0002347567,0.0005048458,0.0011062,0.0005539834,0.0001548924,0.0003079136,0.0000875469,0.0004758084,0.0001141052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003742579,"about_ca_system_score_gemma":0.0003209266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002712578,"about_ca_topic_score_gemma":0.00000210191,"domain_scores_codex":[0.9940242,0.0009577364,0.002378889,0.001200917,0.0007952165,0.0006430428],"domain_scores_gemma":[0.9977461,0.0003692284,0.0003594449,0.000932637,0.00009761612,0.0004950435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07266033,0.02608386,0.0004045095,0.0009067458,0.0008922688,0.0005775723,0.02986317,0.0001755603,0.02287569,0.006111781,0.01081576,0.8286328],"study_design_scores_gemma":[0.02359757,0.07438082,0.0006906099,0.02179687,0.0003668934,0.0001264598,0.007773532,0.04239421,0.006279545,0.0005332514,0.8199832,0.002077032],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9184664,0.05290958,0.0001589576,0.01300937,0.009634317,0.002135733,0.0002953855,0.0006245477,0.002765684],"genre_scores_gemma":[0.978662,0.01603501,0.0001709014,0.0006111028,0.00313352,0.0002198308,0.0005526941,0.0001190471,0.0004959522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8265557,"threshold_uncertainty_score":0.9997403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07169041454626408,"score_gpt":0.436137698945395,"score_spread":0.3644472843991309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}